Evaluation of the Serum Uric Acid Level as an Early Predictor of Mortality Among the Patients with Myocardial Infarction: A Prospective Study

Document Type : Original Article

Authors

1 Department of Microbiology, Institute of Medical Sciences and SUM Hospital, Siksha 'O' Anusandhan University (SOA University), Odisha, India

2 Department of General Medicine, Institute of Medical Sciences and SUM Hospital, Siksha 'O' Anusandhan University (SOA University), Odisha, India

3 Department of Biochemistry, Institute of Medical Sciences and SUM Hospital, Siksha 'O' Anusandhan University (SOA University), Odisha, India

4 Department of Community Medicine, Institute of Medical Sciences and SUM Hospital, Siksha 'O' Anusandhan University (SOA University), Odisha, India

Abstract

Background and aim: Myocardial infarction (MI) is one of the most common causes of death through the globe. Serum uric acid (SUA) is elevated in underlying tissue ischemia. This research conducted to establish the association of SUA extents with MI patients admitted to a tertiary care hospital and to compare SUA levels with Killip Classification as an early prognostic marker in these patients.
Material and methods: Our study involved 100 consecutive AMI patients and 100 age- and sex-matched controls. SUA levels were estimated on the 0th, 3rd, and 7th days of MI and compared with the Killip class, indicative of the severity of heart failure. SUA was measured by the uricase method.
Results: The present study has been undertaken to correlate serum uric acid level as a prognostic marker in patients with myocardial infarction. In myocardial infarction, the higher the uric acid level higher is the risk of mortality. In our study, MI and hypertensive patients had significantly higher SUA levels on days 0, 3, and 7. Also, our study showed SUA levels were significantly larger in patients who belonged to a greater Killip class (Killip III and IV). Among the ten patients who died, eight had SUA levels>7.0 mg/dL during the admission. Among those ten cases, nine patients were in the higher Killip class and one in Killip I class.
Conclusions: Patients with a history of MI and hypertensive have higher SUA levels and are in the greater Killip class. A union of Killip class and SUA after AMI is a good predictor of mortality.

Keywords

Main Subjects


[1] Park K. Park's textbook of preventive and social medicine. Jabalpur. Banarasidas Bhanot. 2011;463.
[2] Wu Y, Pan N, An Y, Xu M, Tan L, Zhang L. Diagnostic and prognostic biomarkers for myocardial infarction. Frontiers in Cardiovascular Medicine. 2021;7:617277. https://doi.org/10.3389/fcvm.2020.617277.
[3] Sautin YY, Johnson RJ. Uric acid: the oxidant-antioxidant paradox. Nucleosides, Nucleotides, and Nucleic Acids. 2008;27(6-7):608-19. https://doi.org/10.1080/15257770802138558.
[4] Chen Y, Tao Y, Zhang L, Xu W, Zhou X. Diagnostic and prognostic value of biomarkers in acute myocardial infarction. Postgraduate medical journal. 2019;95(1122):210-6. http://dx.doi.org/10.1136/postgradmedj-2019-136409.
[5] Arthur S, Sundaram U. Inducible nitric oxide regulates intestinal glutamine assimilation during chronic intestinal inflammation. Nitric Oxide. 2015;44:98-104. https://doi.org/10.1016/j.niox.2014.12.006.
[6] Țăpoi L, Șalaru DL, Sascău R, Stătescu C. Uric Acid—An Emergent Risk Marker for Thrombosis?. Journal of Clinical Medicine. 2021;10(10):2062. https://doi.org/10.3390/jcm10102062.
[7] Batista NV, Barbagallo M, Oliveira VL, Castro-Gomes T, Oliveira RD, Louzada-Junior P, Pinheiro GR, Mantovani A, Teixeira MM, Garlanda C, Amaral FA. The long pentraxin 3 contributes to joint inflammation in gout by facilitating the phagocytosis of monosodium urate crystals. The Journal of Immunology. 2019;202(6):1807-14. https://doi.org/10.4049/jimmunol.1701531.
[8] Sautin YY, Johnson RJ. Uric acid: the oxidant-antioxidant paradox. Nucleosides, Nucleotides, and Nucleic Acids. 2008;27(6-7):608-19. https://doi.org/10.1080/15257770802138558.
[9] Russo B, Menduni M, Borboni P, Picconi F, Frontoni S. Autonomic nervous system in obesity and insulin-resistance—The complex interplay between leptin and central nervous system. International Journal of Molecular Sciences. 2021;22(10):5187. https://doi.org/10.3390/ijms22105187.
[10] Gryszczyńska B, Budzyń M, Formanowicz D, Wanic-Kossowska M, Formanowicz P, Majewski W, Iskra M, Kasprzak MP. Selected atherosclerosis-related diseases may differentially affect the relationship between plasma advanced glycation end products, receptor sRAGE, and uric acid. Journal of clinical medicine. 2020;9(5):1416. http://dx.doi.org/10.3390/jcm9051416.
[11] Martínez MS, García A, Luzardo E, Chávez-Castillo M, Olivar LC, Salazar J, Velasco M, Rojas Quintero JJ, Bermúdez V. Energetic metabolism in cardiomyocytes: molecular basis of heart ischemia and arrhythmogenesis. Vessel Plus. 2017;1:130-41. https://doi.org/ https://doi.org/10.20517/2574-1209.2017.34.
[12] Guieu R, Deharo JC, Maille B, Crotti L, Torresani E, Brignole M, Parati G. Adenosine and the cardiovascular system: The good and the bad. Journal of clinical medicine. 2020;9(5):1366. https://doi.org/10.3390/jcm9051366.
[13] Wang H, Yang J, Sao J, Zhang J, Pang X. The prediction of cardiac events in patients with acute ST segment elevation myocardial infarction: A meta–analysis of serum uric acid. Open life sciences. 2018;13(1):413-21. https://doi.org/10.1515/biol-2018-0050.
[14] Ullah W, Khanal S, Khan R, Basyal B, Munir S, Minalyan A, Alraies MC, Fischman DL. Efficacy of allopurinol in cardiovascular diseases: a systematic review and meta-analysis. Cardiology Research. 2020;11(4):226-32. https://doi.org/10.14740/cr1066.
[15] Brant LC, Barreto SM, Passos VM, Ribeiro AL. Reproducibility of peripheral arterial tonometry for the assessment of endothelial function in adults. Journal of hypertension. 2013;31(10):1984-90. https://doi.org/10.1097/HJH.0b013e328362d913.
[16] Borghi C, Rosei EA, Bardin T, Dawson J, Dominiczak A, Kielstein JT, Manolis AJ, Perez-Ruiz F, Mancia G. Serum uric acid and the risk of cardiovascular and renal disease. Journal of hypertension. 2015;33(9):1729-41. https://doi.org/10.1097/HJH.0000000000000701.
[17] Alem MM, Alshehri AM, Cahusac PM, Walters MR. Effect of xanthine oxidase inhibition on arterial stiffness in patients with chronic heart failure. Clinical Medicine Insights: Cardiology. 2018. https://doi.org/10.1177%2F1179546818779584.
[18] Szyszka M, Skrzypczyk P, Panczyk-Tomaszewska M. URIC ACID IN PEDIATRIC PATIENTS WITH PRIMARY HYPERTENSION. Journal of Hypertension. 2021;39:e189. https://doi.org/10.1097/01.hjh.0000746548.66512.e7.
[19] Farag MM, Ashour EH, El-Hadidy WF. Amelioration of High Fructose Diet-Induced Insulin Resistance, Hyperuricemia, and Liver Oxidative Stress by Combined Use of Selective Agonists of PPAR-α and PPAR-γ in Rats. Dubai Medical Journal. 2020;3(2):76-86. https://doi.org/10.1159/000506899.
[20] Muiesan ML, Agabiti-Rosei C, Paini A, Salvetti M. Uric acid and cardiovascular disease: an update. European Cardiology Review. 2016;11(1):54-9. https://doi.org/10.15420/ecr.2016:4:2.
[21] Yeldandi AV, Patel YD, Liao M, Kao FT, Rao MS, Reddy JK, Le Beau MM. Localization of the human urate oxidase gene (UOX) to 1p22. Cytogenetic and Genome Research. 1992;61(2):121-2. https://doi.org/10.1159/000133386.
[22] Bhattacharya I, Dawson L, Sharma S. Prognostic significance of p53, Ki-67 and Bcl-2 in leukoplakia and squamous cell carcinoma of the oral cavity. National Journal of Laboratory Medicine. 2017;6:16-21.
[23] Nadkar MY, Jain VI. Serum uric acid in acute myocardial infarction. The Journal of the Association of Physicians of India. 2008;56:759-62.
[24] Kojima S, Sakamoto T, Ishihara M, Kimura K, Miyazaki S, Yamagishi M, Tei C, Hiraoka H, Sonoda M, Tsuchihashi K, Shimoyama N. Prognostic usefulness of serum uric acid after acute myocardial infarction (the Japanese Acute Coronary Syndrome Study). The American journal of cardiology. 2005;96(4):489-95. https://doi.org/10.1016/j.amjcard.2005.04.007.
[25] Prashanthi DP, Ganesh B, Jaya N. Role of Serum Uric Acid as a Prognostic Marker in Patients with Acute Myocardial Infarction (AMI). 2019;18(9):6-9. https://doi.org/10.9790/0853-1809020609.
How to Cite this Article: Jena L, Singh S, Nayak SR, Behera B, Panigrahi R, Panigrahi SK. Evaluation of the Serum Uric Acid Level as an Early Predictor of Mortality Among the Patients with Myocardial Infarction: A Prospective Study. International Journal of Scientific Research in Dental and Medical Sciences, 2022;4(2):81-86. http://doi.org/10.30485/IJSRDMS.2022.340472.1293.
 [26] Bonora E, Muggeo M. Postprandial blood glucose as a risk factor for cardiovascular disease in type II diabetes: the epidemiological evidence. Diabetologia. 2001;44(12):2107-14. https://doi.org/10.1007/s001250100020.
[27] Behera SK, Samal AK. Study of serum uric acid level as a prognostic marker in acute ST elevation myocardial infarction patients. Int J Adv Med. 2018;5(3):592-596.
[28] Sokhanvar S, Maleki A. Blood uric acid levels according to cardiovascular disease risk factors in patients with myocardial infarction.
[29] Agrawal S, Aundhkar SC, Patange A, Panpalia NG, Jain S, Garg R. Evaluate the role of serum uric acid in acute myocardial infarction as a prognostic marker. Int J Health Sci Res. 2014;4(5):120-8.
[30] Shetty S, Rao AH, Kumar S, Prakasha SR. Serum Uric Acid as a prognostic biomarker & its correlation with Killip Class in Acute Myocardial Infarction. International Journal of Biomedical Research. 2013;4(7):312-16.
[31] Das A, Gurukul SMKS. Study of Serum Uric Acid Levels in Acute Myocardial Infarction. J Res Med Dent Sci. 2021;9 (5):252-257.
Volume 4, Issue 2
June 2022
Pages 81-86
  • Receive Date: 03 April 2022
  • Revise Date: 25 May 2022
  • Accept Date: 06 June 2022
  • First Publish Date: 06 June 2022